Literature DB >> 7028557

The gastro-entero-pancreatic hormone response to fasting in obesity.

W J Andrews, R W Henry, K G Alberti, K D Buchanan.   

Abstract

A comparison of the metabolic and gastroentero-pancreatic hormonal responses of ten obese and eight lean subjects to 12 h and 36 h fasts has been made. Each subject was given a 50 g oral glucose tolerance test at the end of both 12 h and 36 h starvation. After the 12 h fast blood glucose and 3-hydroxybuty-rate were similar in each group but blood glycerol was 30% higher in the obese subjects. Plasma insulin and vaso-active intestinal polypeptide were also higher in the obese subjects after 12 h starvation. After 36 h starvation in the lean subjects blood glucose was unchanged but on refeeding with 50 g oral glucose, glucose tolerance was impaired. In the same group blood glycerol and 3-hydroxybutyrate rose after 36 h starvation. Plasma glucagon, secretin and vaso-active intestinal polypeptide rose after 36 h starvation in the lean subjects but plasma insulin was unchanged. Refeeding with oral glucose suppressed the increased plasma glucagon, secretin and vaso-active intestinal polypeptide. After the 36 h fast in the obese subjects, blood glucose was unchanged, blood glycerol fell, but blood 3-hydroxybutyrate rose although to a reduced level in comparison with the lean subjects. In the obese group there was no change in plasma glucagon, secretin or vaso-active intestinal polypeptide after 36 h starvation, although plasma insulin fell. The results show different metabolic and gastro-entero-pancreatic hormonal responses to fasting in lean and obese human subjects and suggest an important metabolic role of glucagon, secretin and vaso-active intestinal polypeptide during starvation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7028557     DOI: 10.1007/bf00257783

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  33 in total

1.  STUDIES OF INSULIN AND GROWTH HORMONE SECRETION IN HUMAN OBESITY.

Authors:  P BECK; J H KOUMANS; C A WINTERLING; M F STEIN; W H DAUGHADAY; D M KIPNIS
Journal:  J Lab Clin Med       Date:  1964-10

2.  Plasma free fatty acid concentrations in obesity.

Authors:  L H OPIE; P G WALFISH
Journal:  N Engl J Med       Date:  1963-04-04       Impact factor: 91.245

3.  Immunoreactive glucagon levels in obese-hyperglycemic (ob/ob) mice.

Authors:  P U Dubuc; P W Mobley; R J Mahler; J W Ensinck
Journal:  Diabetes       Date:  1977-09       Impact factor: 9.461

4.  Effect of glucagon on hepatic malonyl coenzyme A concentration and on lipid synthesis.

Authors:  G A Cook; R C Nielsen; R A Hawkins; M A Mehlman; M R Lakshmanan; R L Veech
Journal:  J Biol Chem       Date:  1977-06-25       Impact factor: 5.157

5.  Cell size and lipolysis by human subcutaneous adipose tissue.

Authors:  J Ostman; L Backman; D Hallberg
Journal:  Acta Med Scand       Date:  1973-05

6.  Adenyl cyclase in fat cells. 3. Stimulation by secretin and the effects of trypsin on the receptors for lipolytic hormones.

Authors:  M Rodbell; L Birnbaumer; S L Pohl
Journal:  J Biol Chem       Date:  1970-02-25       Impact factor: 5.157

7.  Extra-gastrointestinal effects of secretin, gastrin, and pancreozymin.

Authors:  N R Lazarus; N R Voyles; S Devrim; T Tanese; L Recant
Journal:  Lancet       Date:  1968-08-03       Impact factor: 79.321

8.  Lipolysis and lipogenesis from glucose in human fat cells of different sizes. Effects of insulin, epinephrine, and theophylline.

Authors:  R B Goldrick; G M McLoughlin
Journal:  J Clin Invest       Date:  1970-06       Impact factor: 14.808

9.  Splanchnic glucose and amino acid metabolism in obesity.

Authors:  P Felig; J Wahren; R Hendler; T Brundin
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

10.  Fasting and prolonged exercise increase vasoactive intestinal polypeptide (VIP) in plasma.

Authors:  H Galbo; J Hilsted; J Fahrenkrug; O B Schaffalitzky De Muckadell
Journal:  Acta Physiol Scand       Date:  1979-03
View more
  3 in total

1.  The plasma concentrations of secretin and vasoactive intestinal polypeptide (VIP) after long-term, strenuous exercise.

Authors:  O Oktedalen; P K Opstad; O B Schaffalitzky de Muckadell
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1983

2.  Failure of fasting to influence the GIP response to oral glucose in non-obese human subjects.

Authors:  W J Andrews; R W Henry; M J Alam; K G Alberti; K D Buchanan
Journal:  Diabetologia       Date:  1983-10       Impact factor: 10.122

Review 3.  Pleiotropic Effects of Secretin: A Potential Drug Candidate in the Treatment of Obesity?

Authors:  Sanna Laurila; Eleni Rebelos; Miikka-Juhani Honka; Pirjo Nuutila
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-04       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.